Alzamend Neuro Inc Alzamend (NASDAQ: ALZN) Submit Pre-IND Request for AL002 to FDA for Alzheimer’s Alzamend Neuro, Inc. (NASDAQ: ALZN) disclosed on Friday that the firm has presented a pre-IND request for AL002 and supporting briefing documents to the Center for Biological Evaluation and Research of the U.S. FDA.
